Processa Pharmaceuticals (PCSA) Q1 2023 Earnings

10MayExpected
May 22
Aug 22
Nov 22
Q1 2023
-0.81
-0.61
-0.4
-0.2

Details

Expected EPS
-0.28
Actual EPS
-0.8115
Surprise EPS
-0.53
Surprise Percent
+189.82%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -0.8115 per share for Q1 2023.

0 Comments

Share your thoughts